Allosteric molecular sensing of anti-HIV antibodies by an immobilized engineered β-galactosidase

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The main objective is to demonstrate the feasibility of qualitative and semi-quantitative determination of anti-HIV antibodies, based on the allosteric response of an immobilized engineered Escherichia coli β-galactosidase. The suitability of this enzyme and the conditions for homogeneous assay had been previously demonstrated. In the present work, the operational conditions for engineered E. coli β-galactosidase immobilization on activated agarose supports have been determined. A solid biocatalyst has been prepared and characterized in order to determine the activation degree of the immobilized enzyme in the presence of anti-HIV antibodies. The solid-phase biocatalyst has been shown to be able to modulate its activity and produce an unequivocal signal in presence of anti-HIV containing sera from different patients. Finally, the conceptual design of a possible assay based on the above methodology is proposed. © 2007 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Ferraz, R. M., Aris, A., González, G., López-Santín, J., Villaverde, A., & Álvaro, G. (2007). Allosteric molecular sensing of anti-HIV antibodies by an immobilized engineered β-galactosidase. Enzyme and Microbial Technology, 41(4), 492–497. https://doi.org/10.1016/j.enzmictec.2007.04.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free